Larvol Delta - Certa-Therapeutics-presents-positive-data-from-a-Phase-2-clinical-study-highlighting-the-potential-benefit-of-FT011-as-a-novel-treatment-for-scleroderma

FT011 - Certa Therap

https://www.globenewswire.com/news-release/2023/11/15/2781377/0/en/Certa-Therapeutics-presents-positive-data-from-a-Phase-2-clinical-study-highlighting-the-potential-benefit-of-FT011-as-a-novel-treatment-for-scleroderma.html

Nov 15, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next